Clinical Trials Directory

Trials / Conditions / Male Hypogonadism

Male Hypogonadism

18 registered clinical trials studyying Male Hypogonadism — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPREDICTORS OF TESTOSTERONE DECLINE IN MIDDLE-AGED MEN
NCT07476222
Andijan State Medical Institute—
Not Yet RecruitingClinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic Hypogonadism
NCT07500766
University of Sao PauloPhase 2
Not Yet RecruitingRelationship of the Microenvironment and Male Fertility
NCT04704141
University of Illinois at Chicago—
UnknownTestosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism
NCT05541172
Hospital de Niños R. Gutierrez de Buenos Aires—
CompletedD-chiroinositol Administration in Hypogonadal Males
NCT04708249
Lo.Li.Pharma s.r.lN/A
Active Not RecruitingTestosterone in Bariatric Patients
NCT03721497
Esbjerg Hospital - University Hospital of Southern DenmarkPhase 4
CompletedStudy to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism
NCT02966652
Neurocrine UK LimitedPhase 1
WithdrawnAutonomic Manifestations of Testosterone Deficiency in Men
NCT02715713
Texas Tech University Health Sciences Center—
CompletedSafety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
NCT02081300
Lipocine Inc.Phase 3
CompletedSafety and Efficacy Trial of Testosterone Undecanoate
NCT01765179
Clarus Therapeutics, Inc.Phase 3
CompletedOpen-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
NCT01699178
Clarus Therapeutics, Inc.Phase 3
CompletedSafety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
NCT01446042
Acerus Pharmaceuticals CorporationPhase 3
CompletedSafety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
NCT01403116
Clarus Therapeutics, Inc.Phase 3
CompletedTime to Eugonadal Range, Time to Steady State and Drying Time
NCT01228071
Endo PharmaceuticalsPhase 3
CompletedPharmacokinetic Study to Determine Time to Steady-state
NCT00911586
Clarus Therapeutics, Inc.Phase 2
CompletedStudy to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation
NCT00924612
Clarus Therapeutics, Inc.Phase 2
CompletedRegistry of Hypogonadism in Men
NCT00858650
Carelon Research—
Completed5-Alpha Reductase and Anabolic Effects of Testosterone
NCT00475501
VA Office of Research and DevelopmentPhase 2